# Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

> **NCT05254782** · — · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 360 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05254782
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-06
- **Primary completion:** 2026-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254782, "Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05254782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*